Nexlizet (bempedoic acid/ezetimibe) / Otsuka, Esperion Therap  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nexlizet (bempedoic acid/ezetimibe) / Esperion Therap, Otsuka
NCT03337308: A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy

Checkmark Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
Completed
3
382
US
Bempedoic Acid + Ezetimibe Fixed-Dose Combination, Bempedoic Acid + Zetia FDC, ETC-1002 + Zetia, Bempedoic Acid, ETC-1002, Ezetimibe, Zetia, Placebos, Placebo
Esperion Therapeutics
Hyperlipidemias
06/18
07/18

Download Options